FDA.reportPublic FDA data

0.5 ML zoster vaccine, recombinant 0.1 MG/ML

RxCUI
1986825
RxNorm name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Display name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Full name
0.5 ML zoster vaccine, recombinant 0.1 MG/ML
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:45

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125614ShingrixZoster Vaccine Recombinant, Adjuvanted351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
0280849d-5c78-4a9d-8941-4eab429f6bd80.5 ML zoster vaccine, recombinant 0.1 MG/MLSY23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd8varicella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL InjectionPSN23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
0280849d-5c78-4a9d-8941-4eab429f6bd80.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML InjectionSCD23These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) injectable suspension, for intramuscular use Initial U.S. Approval: 201720260213
279a251c-f4d0-4c47-b999-7ef1a45ac0d0varicella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL InjectionPSN6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
279a251c-f4d0-4c47-b999-7ef1a45ac0d00.5 ML zoster vaccine, recombinant 0.1 MG/MLSY6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
279a251c-f4d0-4c47-b999-7ef1a45ac0d00.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML InjectionSCD6These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720240109
e9ba0102-8cbb-4c4c-810e-292119095a8a0.5 ML zoster vaccine, recombinant 0.1 MG/MLSY2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415
e9ba0102-8cbb-4c4c-810e-292119095a8a0.5 ML varicella zoster virus glycoprotein E, recombinant 0.1 MG/ML InjectionSCD2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415
e9ba0102-8cbb-4c4c-810e-292119095a8avaricella zoster virus glycoprotein E vaccine recombinant 0.1 MG/mL InjectionPSN2These highlights do not include all the information needed to use SHINGRIX safely and effectively. See full prescribing information for SHINGRIX. SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted), suspension for intramuscular injection Initial U.S. Approval: 201720210415